Exenatide Sensitizes Insulin-Mediated Whole-Body Glucose Disposal and Promotes Uptake of Exogenous Glucose by the Liver

OBJECTIVE— Recent progress suggests that exenatide, a mimetic of glucagon-like peptide-1 (GLP-1), might lower glycemia independent of increased β-cell response or reduced gastrointestinal motility. We aimed to investigate whether exenatide stimulates glucose turnover directly in insulin-responsive t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Dan, Ionut, Viorica, Mooradian, Vahe, Stefanovski, Darko, Bergman, Richard N.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628608/
https://www.ncbi.nlm.nih.gov/pubmed/19011168
http://dx.doi.org/10.2337/db08-0875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628608/
https://www.ncbi.nlm.nih.gov/pubmed/19011168
http://dx.doi.org/10.2337/db08-0875

Ejemplares similares